Latest Hydrazines Stories
-- DUOPA is the first and only treatment providing 16 continuous hours of carbidopa and levodopa for motor fluctuations in advanced Parkinson's disease NORTH CHICAGO, Ill., Jan.
REHOVOT, Israel, October 23, 2014 /PRNewswire/ -- NeuroDerm Ltd., a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, today
REHOVOT, Israel, August 4, 2014 /PRNewswire/ -- NeuroDerm [http://www.neuroderm.com ] Ltd.
MarketPublishers.com announces that a new research study on the monomethylhydrazine (CAS 60-34-4) market created by BAC Reports is available in its catalogue. London,
A new delivery method for levodopa/carbidopa, a common dual-drug Parkinson’s disease (PD) regimen, significantly improved the duration of the drugs’ effectiveness in people with advanced PD,
A levodopa-carbidopa intestinal gel (LCIG) works better than standard oral levodopa-carbidopa in reducing "off" time in patients with advanced Parkinson's disease.
- A woman chauffeur.
- A woman who operates an automobile.